Hovione, a specialist integrated CDMO and provider of spray drying and particle engineering, and Ripple Therapeutics, an ophthalmic sustained drug delivery company, have entered a strategic partnership to expand the use of Ripple’s Epidel® platform beyond ophthalmic applications.    Ripple’s Epidel technology has the ability to deliver sustained-release pharmaceuticals with surface erosion release kinetics without the use of polymers or excipients. This enables higher drug loading, small...